These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32134701)

  • 1. State of the Art: Toward Improving Outcomes of Lung and Liver Tumor Biopsies in Clinical Trials-A Multidisciplinary Approach.
    Levy EB; Fiel MI; Hamilton SR; Kleiner DE; McCall SJ; Schirmacher P; Travis W; Kuo MD; Suh RD; Tam AL; Islam SU; Ferry-Galow K; Enos RA; Doroshow JH; Makhlouf HR
    J Clin Oncol; 2020 May; 38(14):1633-1640. PubMed ID: 32134701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National Cancer Institute's Precision Medicine Initiatives for the new National Clinical Trials Network.
    Abrams J; Conley B; Mooney M; Zwiebel J; Chen A; Welch JJ; Takebe N; Malik S; McShane L; Korn E; Williams M; Staudt L; Doroshow J
    Am Soc Clin Oncol Educ Book; 2014; ():71-6. PubMed ID: 24857062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recommendations for collection and handling of specimens from group breast cancer clinical trials.
    Leyland-Jones BR; Ambrosone CB; Bartlett J; Ellis MJ; Enos RA; Raji A; Pins MR; Zujewski JA; Hewitt SM; Forbes JF; Abramovitz M; Braga S; Cardoso F; Harbeck N; Denkert C; Jewell SD; ; ; ; ; ; ; ; ; ; ; ;
    J Clin Oncol; 2008 Dec; 26(34):5638-44. PubMed ID: 18955459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving Adequacy of Small Biopsy and Fine-Needle Aspiration Specimens for Molecular Testing by Next-Generation Sequencing in Patients With Lung Cancer: A Quality Improvement Study at Dartmouth-Hitchcock Medical Center.
    Padmanabhan V; Steinmetz HB; Rizzo EJ; Erskine AJ; Fairbank TL; de Abreu FB; Tsongalis GJ; Tafe LJ
    Arch Pathol Lab Med; 2017 Mar; 141(3):402-409. PubMed ID: 27763790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward Improving Practices for Submission of Diagnostic Tissue Blocks for National Cancer Institute Clinical Trials.
    Makhlouf H; Watson MA; Lankes HA; Weil C; Dickler M; Birrer M; Moskaluk C; Ramirez NC; Okby N; Alonsozana E; Barnes M; Goldman EB; Enos R; Lubensky I
    Am J Clin Pathol; 2020 Jan; 153(2):149-155. PubMed ID: 31613330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical Care Network in the State of Qatar.
    Hijjeh M; Al Shaikh L; Alinier G; Selwood D; Malmstrom F; Hassan IF
    Qatar Med J; 2019; 2019(2):2. PubMed ID: 31763205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidelines for the development and incorporation of biomarker studies in early clinical trials of novel agents.
    Dancey JE; Dobbin KK; Groshen S; Jessup JM; Hruszkewycz AH; Koehler M; Parchment R; Ratain MJ; Shankar LK; Stadler WM; True LD; Gravell A; Grever MR;
    Clin Cancer Res; 2010 Mar; 16(6):1745-55. PubMed ID: 20215558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiologic Considerations and Standardization of Malignant Pleural Mesothelioma Imaging Within Clinical Trials: Consensus Statement from the NCI Thoracic Malignancy Steering Committee - International Association for the Study of Lung Cancer - Mesothelioma Applied Research Foundation Clinical Trials Planning Meeting.
    Gill RR; Tsao AS; Kindler HL; Richards WG; Armato SG; Francis RJ; Gomez DR; Dahlberg S; Rimner A; Simone CB; de Perrot M; Blumenthal G; Adjei AA; Bueno R; Harpole DH; Hesdorffer M; Hirsch FR; Pass HI; Yorke E; Rosenzweig K; Burt B; Fennell DA; Lindwasser W; Malik S; Peikert T; Mansfield AS; Salgia R; Yang H; Rusch VW; Nowak AK
    J Thorac Oncol; 2019 Oct; 14(10):1718-1731. PubMed ID: 31470129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lessons learned from clinical trial queries on small biopsy collections: importance of rapid on-site evaluation.
    Voyten J; Holtzman MP; Pantanowitz L; Dhir R; Beasley HS; Cuda J; Monaco SE
    J Am Soc Cytopathol; 2020; 9(5):461-468. PubMed ID: 32499137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility, safety, and adequacy of research biopsies for cancer clinical trials at an academic medical center.
    Lee K; Lee SJ; Yoon S; Ryoo BY; Kim SW; Choi SH; Lee SM; Chae EJ; Park Y; Jang SJ; Park SY; Yoon YK; Park SH; Kim TW
    PLoS One; 2019; 14(8):e0221065. PubMed ID: 31404103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determining the Optimal Number of Core Needle Biopsy Passes for Molecular Diagnostics.
    Hoang NS; Ge BH; Pan LY; Ozawa MG; Kong CS; Louie JD; Shah RP
    Cardiovasc Intervent Radiol; 2018 Mar; 41(3):489-495. PubMed ID: 29279975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishing the diagnosis of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
    Rivera MP; Mehta AC; Wahidi MM
    Chest; 2013 May; 143(5 Suppl):e142S-e165S. PubMed ID: 23649436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid fine needle aspiration cytology: a review of the National Cancer Institute state of the science symposium.
    Layfield LJ; Cibas ES; Baloch Z
    Cytopathology; 2010 Apr; 21(2):75-85. PubMed ID: 21054821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consensus report of a joint NCI thoracic malignancies steering committee: FDA workshop on strategies for integrating biomarkers into clinical development of new therapies for lung cancer leading to the inception of "master protocols" in lung cancer.
    Malik SM; Pazdur R; Abrams JS; Socinski MA; Sause WT; Harpole DH; Welch JJ; Korn EL; Ullmann CD; Hirsch FR
    J Thorac Oncol; 2014 Oct; 9(10):1443-8. PubMed ID: 25521397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ongoing Use of Data and Specimens From National Cancer Institute-Sponsored Cancer Prevention Clinical Trials in the Community Clinical Oncology Program.
    Minasian LM; Tangen CM; Wickerham DL
    Semin Oncol; 2015 Oct; 42(5):748-63. PubMed ID: 26433556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of interventional radiology in clinical trial teams: experience from the BATTLE lung cancer trials.
    Tam AL; Papadimitrakopoulou V; Wistuba II; Lee JJ; Ensor JE; Kim ES; Kalhor N; Blumenschein GR; Tsao AS; Heymach JV; Herbst RS; Hicks ME; Hong WK; Gupta S
    Clin Radiol; 2021 Feb; 76(2):155.e25-155.e34. PubMed ID: 33268083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes and efficacy of thoracic surgery biopsy for tumor molecular profiling in patients with advanced lung cancer.
    Cooke DT; Gandara DR; Goodwin NC; Calhoun RF; Lara PN; Mack PC; David EA
    J Thorac Cardiovasc Surg; 2014 Jul; 148(1):36-40. PubMed ID: 24746995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue diagnosis of suspected lung cancer: selecting between bronchoscopy, transthoracic needle aspiration, and resectional biopsy.
    Yung RC
    Respir Care Clin N Am; 2003 Mar; 9(1):51-76. PubMed ID: 12820712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.